L. Ministère-de and . Santé, Annuaire des statistiques sanitaires, vol.147, 2012.

P. B. Bloland, Drug resistance in malaria. Chamblee, GA: Malaria Epidemiology Branch Centers for Disease Control and Prevention, 2001.

, Malaria control today: current WHO recommendations. Geneva: World Health Organization, 2005.

N. J. White and P. L. Olliaro, Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria, Parasitol Today, vol.12, pp.399-401, 1996.

R. N. Price, F. Nosten, C. Luxemburger, F. O. Ter-kuile, L. Paiphun et al., Effects of artemisinin derivatives on malaria transmissibility, Lancet, vol.347, pp.1654-1662, 1996.

, Guidelines for the treatment of malaria, 2011.

B. Faye, Y. Dieng, F. O. Gaye, and O. , Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal, Malar J, vol.6, p.80, 2006.

I. Sagara, A. Diallo, M. Kone, M. Coulibaly, S. I. Diawara et al., A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali, Am J Trop Med Hyg, vol.79, pp.655-61, 2008.

S. Youdom, W. R. Tahar, V. N. Foumane, G. Soula, H. Gwét et al., Efficacy of non-artemisinin-and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon, Malar J, vol.9, p.56, 2010.

, The status of drug-resistant malaria along the Thailand-Myanmar border

M. D. Spring, J. T. Lin, J. E. Manning, P. Vanachayangkul, S. Somethy et al., Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study, Lancet Infect Dis, vol.15, pp.683-91, 2015.

, Geneva: World Health Organization, WHO. World malaria report, 2012.

, Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization, 2009.

A. Yadouléton, R. N'guessan, H. Allagbé, A. Asidi, M. Boko et al., The impact of the expansion of urban vegetable farming on malaria transmission in major cities of Benin, Parasit Vectors, vol.3, p.118, 2010.

, WHO/Communicable diseases cluster. Severe falciparum malaria, Trans R Soc Trop Med Hyg, vol.94, pp.1-90, 2000.

, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organization, 2003.

, Malaria fact sheet No. 94. Geneva: World Health Organization, 1996.

W. J. Collins, B. Greenhouse, P. J. Rosenthal, and G. Dorsey, The use of genotyping in anti-malarial clinical trials: a systematic review of published studies from 1995-2005, Malar J, vol.5, p.122, 2006.

, Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Geneva: World Health Organization, 2008.

G. Snounou, X. Zhu, N. Siripoon, W. Jarra, S. Thaithong et al., Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand, Trans R Soc Trop Med Hyg, vol.93, pp.369-77, 1999.

A. Ogouyèmi-hounto, N. K. Ndam, G. Fadégnon, C. Azagnandji, M. Bello et al., Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin, Malar J, vol.12, p.413, 2013.

H. Tinto, S. Diallo, I. Zongo, I. Guiraud, I. Valea et al., Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial, Trop Med Int Health, vol.19, pp.469-75, 2014.

, Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Geneva: World Health Organization, p.2007, 2007.

A. Shayo, C. I. Mandara, F. Shahada, J. Buza, M. M. Lemnge et al., Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania, Malar J, vol.13, p.376, 2014.

B. Hamainza, F. Masaninga, H. Moonga, M. Mwenda, P. Chanda-kapata et al., Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia, Malar J, vol.13, p.430, 2014.

D. Kinde-gazard, A. Ogouyèmi-hounto, L. Capo-chichi, J. Gbaguidi, and A. Massougbodji, Essai clinique randomisé comparant l'efficacité et la tolérance de la combinaison Artémisinine-Naphthoquine

. Artéméther-luméfantrine, Coartem ® ) dans le traitement du paludisme simple au Bénin, vol.105, pp.208-222, 2012.

S. Abdulla, I. Sagara, S. Borrmann, D. '-alessandro, U. González et al., Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial, Lancet, vol.372, pp.1819-1846, 2008.

P. Chanda, M. Hawela, M. Kango, and N. Sipilanyambe, Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane ® ) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia, Malar J, vol.5, p.75, 2006.

B. E. Ngasala, M. Malmberg, A. M. Carlsson, P. E. Ferreira, M. G. Petzold et al., Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial, Clin Infect Dis, vol.52, pp.873-82, 2011.

J. Song, D. Socheat, B. Tan, S. Seila, Y. Xu et al., Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area, Malar J, vol.10, p.231, 2011.

D. Djallé, S. P. Njuimo, A. Manirakiza, R. Laganier, A. L. Faou et al., Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial, Malar J, vol.13, p.9, 2014.

M. Nambozi, J. P. Van-geertruyden, S. Hachizovu, M. C. Doreen, M. D. Mulenga et al., Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children, Malar J, vol.10, p.50, 2011.

P. Sondo, K. Derra, S. Diallo-nakanabo, Z. Tarnagda, O. Zampa et al., Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Malar J, vol.14, p.325, 2015.

I. Sagara, B. Fofana, J. Gaudart, B. Sidibe, A. Togo et al., Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact, Am J Trop Med Hyg, vol.87, pp.50-56, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01307775

F. Ezzet, M. Van-vugt, F. Nosten, S. Looareesuwan, and N. J. White, Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria, Antimicrob Agents Chemother, vol.44, pp.697-704, 2000.

, Product monograph, 2010.

A. Ndayiragije, D. Niyungeko, J. Karenzo, E. Niyungeko, M. Barutwanayo et al., Efficacité de combinaisons thérapeutiques avec des dérivés de l'artémisinine dans le traitement de l'accès palustre non-compliqué au Burundi, Trop Med Int Health, vol.9, pp.673-682, 2004.

B. Schramm, P. Valeh, E. Baudin, C. S. Mazinda, R. Smith et al., Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. Malar J, vol.12, p.250, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00854378

A. Assefa, M. Kassa, G. Tadese, H. Mohamed, A. Animut et al., Therapeutic efficacy of artemether/lumefantrine (Coartem ® ) against Plasmodium falciparum in Kersa, South West Ethiopia. Parasit Vectors, vol.3, p.1, 2010.

R. Tine, B. Faye, K. Sylla, J. L. Ndiaye, M. Ndiaye et al., Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial, Malar J, vol.11, p.416, 2012.

A. Salissou, B. M. Halima, M. Abani, E. Adehossi, M. Daou et al., efficacité et tolérance de l'association artemether lumefantrine dans le traitement du paludisme simple à Plasmodium falciparum au Niger, J Rech Sci Univ Lomé), vol.14, pp.79-84, 2012.

O. S. Michael, G. O. Gbotosho, O. A. Folarin, T. Okuboyejo, A. Sowunmi et al., Early variations in Plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance, Malar J, vol.22, p.335, 2010.

, WHO. Global Malaria Programme. Status report on artemisinin resistance. Geneva: World Health Organization, 2014.

Z. G. Premji, Coartem ® : the journey to the clinic, Malar J, vol.8, issue.1, p.3, 2009.

M. Ndounga, P. I. Mayengue, P. N. Casimiro, D. Loumouamou, L. K. Basco et al., Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville, Malar J, vol.12, p.53, 2013.